This site has limited support for your browser. We recommend switching to Edge, Chrome, Safari, or Firefox.

What is Bacterial Vaginosis?

Bacterial Vaginosis (BV) is an infective disturbance of the vaginal microbiome.

BV is caused by high levels of anaerobic bacteria in the vagina, such as Gardnerella vaginalis.

The vaginal microbiota is key and instrumental to maintaining natural vaginal health. BV behaves like an STI and can be acquired sexually. It can also occur spontaneously as a result of disturbance of the “good bacteria” of the natural microbiome, mainly the soldier bacteria lactobacilli. Examples of factors that may cause disturbance of the natural microbiome include non-Ph balanced vaginal lubricants, feminine washes, antibiotic therapy, and wearing non breathing, tight synthetic fabrics such as underwear, leggings and tights.

A relationship has been suspected between BV and HPV (human papilloma virus) infection.

Symptoms of BV can be described as vaginal discomfort accompanied by an offensive odour and excessive smelly discharge that can be yellow or green in colour. Itch may be a presenting symptom and can be accompanied by discharge and an elevated vaginal pH.

BV affects women of reproductive age and in its extremes may be asymptomatic or symptomatic.

Having BV can increase a woman’s risk of contracting other infections sexually (STIs) including Chlamydia trachomatis, trichomonas vaginalis, HIV and herpes simplex.

While antibiotic treatments can be immediately effective, this can be temporary as recurrence rates are high.

Current literature has suggested a link between BV susceptibility and menstrual cycle stage, suggesting new BV infections are most common in the first week of the female natural menstrual cycle.

Treatments for BV include local or systemic antibiotic therapies, often applying clindamycin or metronidazole therapy, followed by probiotic support.

Equilibrium formulated lubricant can also be used as a daily treatment. Ellechemy recommends choosing rich our aqueous cream base if you plan to use this Ellechemist as a daily treatment. This formulation contains the active ingredient boric acid which regulates vaginal pH to optimise protective lactobacillus recolonisation and sustained re-establishment.

Equilibrium also contains active probiotic and antipathogenic elements derived from coconut oil and manuka honey to support a healthy, resilient vaginal microbiome. Your best protection against recurrent BV is balance.


Coudray MS, Madhivanan P. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:143-148. doi: 10.1016/j.ejogrb.2019.12.035. Epub 2019 Dec 24. PMID: 31901667; PMCID: PMC6989391.

Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955;69(5):962–76. [PubMed] [Google Scholar]

 Holzman C, Leventhal JM, Qiu H, Jones NM, Wang J, Group BVS. Factors linked to bacterial vaginosis in nonpregnant womenAm J Public Health. 2001;91(10):1664–70. [PMC free article] [PubMed[Google Scholar]

Ranjit E, Raghubanshi BR, Maskey S, Parajuli P. Prevalence of Bacterial Vaginosis and Its Association with Risk Factors among Nonpregnant Women: A Hospital Based Study. Int J Microbiol. 2018;2018:8349601. [PMC free article] [PubMed] [Google Scholar]

Schwebke JR, Desmond R. Natural history of asymptomatic bacterial vaginosis in a high-risk group of women. Sexually transmitted diseases. 2007;34(11):876–7. [PubMed] [Google Scholar]

Morris MC, Rogers PA, Kinghorn GR. Is bacterial vaginosis a sexually transmitted infection? Sex Transm Infect. 2001;77(1):63–8. [PMC free article] [PubMed] [Google Scholar]

Bautista CT, Wurapa E, Sateren WB, Morris S, Hollingsworth B, Sanchez JL. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res. 2016;3:4. [PMC free article] [PubMed] [Google Scholar]